Can Brain-Derived Neurotrophic Factor Be Considered a Biomarker for Bipolar Disorder? An Analysis of the Current Evidence

Overview

Journal Brain Sci

Publisher MDPI

Date 2023 Aug 26

PMID 37626577

Authors

Gianmarco De Felice

Mario Luciano

Alessia Boiano

Giulia Colangelo

Pierluigi Catapano

Bianca Della Rocca

Maria Vita Lapadula

Elena Piegari

Claudia Toni

Andrea Fiorillo

Affiliations

Soon will be listed here.

Abstract

Brain-derived neurotrophic factor (BDNF) plays a key role in brain development, contributing to neuronal survival and neuroplasticity. Previous works have found that BDNF is involved in several neurological or psychiatric diseases. In this review, we aimed to collect all available data on BDNF and bipolar disorder (BD) and assess if BDNF could be considered a biomarker for BD. We searched the most relevant medical databases and included studies reporting original data on BDNF circulating levels or Val66Met polymorphism. Only articles including a direct comparison with healthy controls (HC) and patients diagnosed with BD according to international classification systems were included. Of the 2430 identified articles, 29 were included in the present review. Results of the present review show a reduction in BDNF circulating levels during acute phases of BD compared to HC, which increase after effective therapy of the disorders. The Val66Met polymorphism was related to features usually associated with worse outcomes. High heterogeneity has been observed regarding sample size, clinical differences of included patients, and data analysis approaches, reducing comparisons among studies. Although more studies are needed, BDNF seems to be a promising biomarker for BD.

Citing Articles

Job burnout, cognitive functioning, and Brain-derived neurotrophic factor expression among hospital Mexican nurses.

Cortes-Alvarez N, Lara-Morales A, Bautista-Rodriguez E, Marmolejo-Murillo L, Diaz Jimenez A, Vergara Hernandez L PLoS One. 2024; 19(5):e0304092.

PMID: 38787900 PMC: 11125546. DOI: 10.1371/journal.pone.0304092.

Biological correlates of treatment resistant depression: a review of peripheral biomarkers.

Mancuso E, Sampogna G, Boiano A, Della Rocca B, Di Vincenzo M, Lapadula M Front Psychiatry. 2023; 14:1291176.

PMID: 37941970 PMC: 10628469. DOI: 10.3389/fpsyt.2023.1291176.

References

Li S, Tollefsbol T . DNA methylation methods: Global DNA methylation and methylomic analyses. Methods. 2020; 187:28-43. PMC: 7914139. DOI: 10.1016/j.ymeth.2020.10.002. View

Jacoby A, Munkholm K, Vinberg M, Pedersen B, Kessing L . Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study. J Affect Disord. 2016; 197:167-74. DOI: 10.1016/j.jad.2016.03.040. View

Isgren A, Sellgren C, Ekman C, Holmen-Larsson J, Blennow K, Zetterberg H . Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes. Brain Behav Immun. 2017; 65:195-201. DOI: 10.1016/j.bbi.2017.05.002. View

Waszczuk M . The utility of hierarchical models of psychopathology in genetics and biomarker research. World Psychiatry. 2021; 20(1):65-66. PMC: 7801832. DOI: 10.1002/wps.20811. View

Giacobbo B, Doorduin J, Klein H, Dierckx R, Bromberg E, de Vries E . Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation. Mol Neurobiol. 2018; 56(5):3295-3312. PMC: 6476855. DOI: 10.1007/s12035-018-1283-6. View

Teng Z, Wang L, Li S, Tan Y, Qiu Y, Wu C . Low BDNF levels in serum are associated with cognitive impairments in medication-naïve patients with current depressive episode in BD II and MDD. J Affect Disord. 2021; 293:90-96. DOI: 10.1016/j.jad.2021.06.018. View

Steardo Jr L, Carbone E, Ventura E, de Filippis R, Luciano M, Segura-Garcia C . Dissociative Symptoms in Bipolar Disorder: Impact on Clinical Course and Treatment Response. Front Psychiatry. 2021; 12:732843. PMC: 8572831. DOI: 10.3389/fpsyt.2021.732843. View

Aas M, Dieset I, Morch R, Steen N, Hope S, Reponen E . Reduced brain-derived neurotrophic factor is associated with childhood trauma experiences and number of depressive episodes in severe mental disorders. Schizophr Res. 2018; 205:45-50. DOI: 10.1016/j.schres.2018.08.007. View

Hernandorena C, Baldessarini R, Tondo L, Vazquez G . Status of Type II vs. Type I Bipolar Disorder: Systematic Review with Meta-Analyses. Harv Rev Psychiatry. 2023; 31(4):173-182. DOI: 10.1097/HRP.0000000000000371. View

10.

Singh C, Roy-Chowdhuri S . Quantitative Real-Time PCR: Recent Advances. Methods Mol Biol. 2016; 1392:161-76. DOI: 10.1007/978-1-4939-3360-0_15. View

11.

Colucci-DAmato L, Speranza L, Volpicelli F . Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. Int J Mol Sci. 2020; 21(20). PMC: 7589016. DOI: 10.3390/ijms21207777. View

12.

Fernandes B, Gama C, Kauer-SantAnna M, Lobato M, Belmonte-de-Abreu P, Kapczinski F . Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J Psychiatr Res. 2009; 43(15):1200-4. DOI: 10.1016/j.jpsychires.2009.04.010. View

13.

Lang U, Ramsay H, Yates K, Veijola J, Gyllenberg D, Clarke M . Potential for prediction of psychosis and bipolar disorder in Child and Adolescent Mental Health Services: a longitudinal register study of all people born in Finland in 1987. World Psychiatry. 2022; 21(3):436-443. PMC: 9453911. DOI: 10.1002/wps.21009. View

14.

van den Ameele S, Coppens V, Schuermans J, de Boer P, Timmers M, Fransen E . Neurotrophic and inflammatory markers in bipolar disorder: A prospective study. Psychoneuroendocrinology. 2017; 84:143-150. DOI: 10.1016/j.psyneuen.2017.07.003. View

15.

Tycko B . Epigenetic gene silencing in cancer. J Clin Invest. 2000; 105(4):401-7. PMC: 289180. DOI: 10.1172/JCI9462. View

16.

Aydin S . A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides. 2015; 72:4-15. DOI: 10.1016/j.peptides.2015.04.012. View

17.

Lotrich F, Albusaysi S, Ferrell R . Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment. Neuropsychopharmacology. 2013; 38(6):985-95. PMC: 3629388. DOI: 10.1038/npp.2012.263. View

18.

Karege F, Schwald M, Cisse M . Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002; 328(3):261-4. DOI: 10.1016/s0304-3940(02)00529-3. View

19.

Edelmann E, Lessmann V, Brigadski T . Pre- and postsynaptic twists in BDNF secretion and action in synaptic plasticity. Neuropharmacology. 2013; 76 Pt C:610-27. DOI: 10.1016/j.neuropharm.2013.05.043. View

20.

Haarman B, Riemersma-van der Lek R, de Groot J, Ruhe H, Klein H, Zandstra T . Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study. Brain Behav Immun. 2014; 40:219-25. DOI: 10.1016/j.bbi.2014.03.016. View